He-qi Bu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Oridonin enhances the anti-tumor activity of gemcitabine towards pancreatic cancer by stimulating Bax- and Smac-dependent apoptosis.
Journal: Translational cancer research
Published: December 28, 2019
The inhibitory effect of oridonin on colon cancer was mediated by deactivation of TGF-β1/Smads-PAI-1 signaling pathway in vitro and vivo.
Journal: OncoTargets and therapy
Published: June 22, 2019
Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells.
Journal: Oncology reports
Published: February 05, 2015
Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway.
Journal: Molecular medicine reports
Published: April 09, 2014
Involvement of the phosphoinositide 3-kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1.
Journal: Oncology letters
Published: July 23, 2012
Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway.
Journal: International journal of oncology
Published: March 10, 2012
Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.
Journal: International journal of oncology
Published: November 13, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026